Coronavirus vaccine update: Oxford, Pfizer vaccines safe, give immunity

There are 23 coronavirus vaccine candidates in human trials, including Moderna, AstraZeneca Plc, BioNTech, Novavax, Sinovac, CanSino Biologics and Inovio. Catch latest updates on Covid-19 vaccine

In a major breakthrough, the early-stage human trial data has revealed that the coronavirus vaccine candidate developed by AstraZeneca and Oxford University is safe. German biotech firm BioNTech and US drugmaker Pfizer also reported that their experimental Covid-19 vaccine was safe and induced an immune response in patients. 

The latest developments raise hope as these could contribute to ending the pandemic, which has infected over 14.7 million people worldwide and claimed over 600,000 lives so far. More than 150 possible vaccines are being developed and tested around the world, including in India, Britain, China, the US, Russia and Israel to try to stop the pandemic. At present, 23 vaccine candidates are in human clinical trials. These include those of Moderna, AstraZeneca Plc, BioNTech, Novavax, Sinovac, CanSino Biologics and Inovio Pharmaceuticals.

Coronavirus treatment: Updates on coronavirus vaccine/drug development:

Oxford coronavirus vaccine update: Vaccine safe, gives immunity

The early-stage human trial data has revealed that the Covid-19 vaccine candidate developed by AstraZeneca and Oxford University is safe and induces immune response, with mild side effects in some participants, which scientists say can be treated with the commonly available pain medication paracetamol. 

The preliminary results of the Phase-I and -II trials, published in The Lancet journal, involved 1,107 healthy adults, and found that the vaccine induced an immune response, both via antibodies and the T-cells of the immune system, up to day 56 of the ongoing trial…